Brelgometon
| Clinical data | |
|---|---|
| Other names | ATH-1105; ATH1105 |
| Drug class | Hepatocyte growth factor (HGF)–c-MET signaling positive modulator; Neuroprotective agent; Anti-inflammatory drug |
| Identifiers | |
| |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C21H28F3N3O2 |
| Molar mass | 411.469 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Brelgometon (INN; developmental code name ATH-1105) is a positive modulator of hepatocyte growth factor (HGF)–c-MET signaling which is under development for the treatment of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).[1][2][3][4] It is a small-molecule and has favorable drug-like properties, such as oral bioavailability and blood–brain barrier permeabiliy.[3][4] The drug shows potent neuroprotective and anti-inflammatory effects in preclinical research, including in models of ALS.[3][4] It was originated by Athira Pharma and is under development by LeonaBio.[1][2] As of April 2026, the drug is in phase 1 clinical trials for ALS and is in the preclinical research stage of development for FTD.[1][2] A phase 2 trial for ALS is being planned for the second half of 2026.[1]
See also
[edit]References
[edit]- 1 2 3 4 "Brelgometon - LeonaBio". adisinsight.springer.com. Retrieved 27 October 2026.
- 1 2 3 "Delving into the Latest Updates on ATH-1105 with Synapse". Synapse. 24 October 2026. Retrieved 27 October 2026.
- 1 2 3 Berthiaume AA, Reda SM, Kleist KN, Setti SE, Wu W, Johnston JL, et al. (2024). "ATH-1105, a small-molecule positive modulator of the neurotrophic HGF system, is neuroprotective, preserves neuromotor function, and extends survival in preclinical models of ALS". Frontiers in Neuroscience. 18 1348157. doi:10.3389/fnins.2024.1348157. PMC 10881713. PMID 38389786.
- 1 2 3 Berthiaume AA, Kleist KN, Reda SM, Setti SE, Wu W, Johnston JL, et al. (2025). "ATH-1105 mitigates multiple pathologies in ALS models both alone and in combination with riluzole". Frontiers in Neurology. 16 1582765. doi:10.3389/fneur.2025.1582765. PMC 12825224. PMID 41586107.